Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00001532Recruiting

Role of Genetic Factors in the Development of Lung Disease

Role: collaborator

NCT00024635Recruiting

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

Role: collaborator

NCT03252093Phase 2Terminated

Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

Role: collaborator

NCT01639937Terminated

Myocardial Perfusion and Scarring in Congenital Heart Disease

Role: collaborator

NCT01547780Phase 1Completed

Translocator Protein and Inflammation After Traumatic Brain Injury

Role: collaborator

All 5 trials loaded